We have French content available. View French site.

Étude de cas

Pharma oncology growth strategy

A leading player in the oncology market was seeking to grow in the face of increasing competition, regulation and other pressures. Bain created a framework to help the pharmaceutical company optimize its portfolio to support the company's revenue goals, and developed a plan for the company to close the revenue gap by making the most of its existing investments.

  • min

Toute l’histoire

The Situation

  • Pharma Co.* is a leading player in the oncology market and wants to grow and retain its competitive position
  • Oncology market is growing, but is increasingly competitive and increasingly impacted by payers/regulators
  • Pharma Co.'s current portfolio does not support revenue goals within oncology
  • Project prioritization is complex due to uncertainty of compounds having multiple indications
  • Existing process and tools are not effective for making strategic trade-offs for single compounds and entire portfolio

Our Approach

Improve the NPD process:

The Recommendations

Develop a framework to optimize portfolio decisions:

The Results

Plan developed to close the revenue gap:

* We take our clients' confidentiality seriously. While we've changed their names, the results are real.

Comment nous avons aidé nos clients

Stratégie Review focuses biotech on portfolio potential

Lire l’étude de cas

Divestiture adds value to parent, subsidiary

Lire l’étude de cas

Stratégie Client et Marketing Pharma go-to-market strategy

Lire l’étude de cas

Vous souhaitez continuer cette conversation ?

Nous aidons des dirigeants du monde entier à matérialiser des impacts et des résultats pérennes et créateurs de valeur dans leurs organisations.

Contacter Bain

Comment pouvons-nous vous aider ?

Voir tous les bureaux